» Articles » PMID: 32855655

Alginate/Pluronic F127-based Encapsulation Supports Viability and Functionality of Human Dental Pulp Stem Cell-derived Insulin-producing Cells

Overview
Journal J Biol Eng
Publisher Biomed Central
Date 2020 Aug 29
PMID 32855655
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Current approach for diabetes treatment remained several adverse events varied from gastrointestinal to life-threatening symptoms. Regenerative therapy regarding Edmonton protocol has been facing serious limitations involving protocol efficiency and safety. This led to the study for alternative insulin-producing cell (IPC) resource and transplantation platform. In this study, evaluation of encapsulated human dental pulp-derived stem cell (hDPSC)-derived IPCs by alginate (ALG) and pluronic F127-coated alginate (ALGPA) was performed.

Results: The results showed that ALG and ALGPA preserved hDPSC viability and allowed glucose and insulin diffusion in and out. ALG and ALGPA-encapsulated hDPSC-derived IPCs maintained viability for at least 336 h and sustained pancreatic endoderm marker ), pancreatic islet markers ( and ), and intracellular pro-insulin and insulin expressions for at least 14 days. Functional analysis revealed a glucose-responsive C-peptide secretion of ALG- and ALGPA-encapsulated hDPSC-derived IPCs at 14 days post-encapsulation.

Conclusion: ALG and ALGPA encapsulations efficiently preserved the viability and functionality of hDPSC-derived IPCs in vitro and could be the potential transplantation platform for further clinical application.

Citing Articles

Immune Evasion in Stem Cell-Based Diabetes Therapy-Current Strategies and Their Application in Clinical Trials.

Mu-U-Min R, Diane A, Allouch A, Al-Siddiqi H Biomedicines. 2025; 13(2).

PMID: 40002796 PMC: 11853723. DOI: 10.3390/biomedicines13020383.


Establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell-derived insulin-producing cells.

Tran H, Rodprasert W, Padeta I, Oontawee S, Purbantoro S, Thongsit A PLoS One. 2025; 20(1):e0318204.

PMID: 39883721 PMC: 11781742. DOI: 10.1371/journal.pone.0318204.


Trends of regenerative tissue engineering for oral and maxillofacial reconstruction in veterinary medicine.

Purbantoro S, Taephatthanasagon T, Purwaningrum M, Hirankanokchot T, Peralta S, Fiani N Front Vet Sci. 2024; 11:1325559.

PMID: 38450027 PMC: 10915013. DOI: 10.3389/fvets.2024.1325559.


Differentiation of Alginate-Encapsulated Wharton Jelly-Derived Mesenchymal Stem Cells into Insulin Producing Cells.

Poursafavi Z, Abroun S, Kaviani S, Roodbari N Cell J. 2022; 24(8):449-457.

PMID: 36093804 PMC: 9468719. DOI: 10.22074/cellj.2022.8081.


Osteogenic growth peptide enhances osteogenic differentiation of human periodontal ligament stem cells.

Purbantoro S, Osathanon T, Nantavisai S, Sawangmake C Heliyon. 2022; 8(7):e09936.

PMID: 35874053 PMC: 9304736. DOI: 10.1016/j.heliyon.2022.e09936.


References
1.
Cho N, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A . IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138:271-281. DOI: 10.1016/j.diabres.2018.02.023. View

2.
Dembczynski R, Jankowski T . Determination of pore diameter and molecular weight cut-off of hydrogel-membrane liquid-core capsules for immunoisolation. J Biomater Sci Polym Ed. 2002; 12(9):1051-8. DOI: 10.1163/156856201753252552. View

3.
Shivakumar S, Lee H, Son Y, Bharti D, Ock S, Lee S . differentiation of single donor derived human dental mesenchymal stem cells into pancreatic β cell-like cells. Biosci Rep. 2019; 39(5). PMC: 6527933. DOI: 10.1042/BSR20182051. View

4.
Santos-Vizcaino E, Orive G, Pedraz J, Hernandez R . Clinical Applications of Cell Encapsulation Technology. Methods Mol Biol. 2020; 2100:473-491. DOI: 10.1007/978-1-0716-0215-7_32. View

5.
Handelsman Y, Bloomgarden Z, Grunberger G, Umpierrez G, Zimmerman R, Bailey T . American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. Endocr Pract. 2015; 21 Suppl 1:1-87. PMC: 4959114. DOI: 10.4158/EP15672.GL. View